Prostatic Diseases: Clinical Trials

131 trials for Prostatic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

131 completed. 131 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4131Completed 131

Follow Prostatic Diseases: new trials by email Literature Review of Prostatic Diseases trials Research Report on Prostatic Diseases

Trials (filtered) newest first · largest first

All 131 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
flotufolastat (18F), piflufolastat (18F) - Prostate Cancer
Phase 4CompletedBlue Earth Diagnostics622024-12-042026-07-13
The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder.
Pyridostigmine oral tablet, Placebo - Underactive Bladder, TURP(transurethral Resection of Prostate)
Phase 4CompletedMenoufia University662024-04-012025-03-26
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Piflufolastat F 18 Intravenous Solution [PYLARIFY] - Prostate Cancer
Phase 4CompletedLantheus Medical Imaging2792024-02-082026-11-17
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients With Prostate Volumes ≤ 40 ml: A Prospective Comparative Study
Tamsulosin 0.4 mg, Tadalafil 5mg, Tamsulosin and Tadalafil - BPH With Other Lower Urinary Tract Symptoms
Phase 4CompletedFayoum University Hospital952023-04-202025-02-05
Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms
FICOXPEA® is an oral combination of Phycocyanin, Palmitoylethanolamide and selenium - Chronic Prostatitis (CP), Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Phase 4CompletedClinica Urologica Molinette - Città della Saliute e della Scienza482022-11-022025-07-24
The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
Silodosin, Tamsolusin - BPH (Benign Prostatic Hyperplasia)
Phase 4CompletedShanghai Huilun Pharmaceutical Co., Ltd.1102022-07-182025-08-21
Oral Fosfomycin as Sequential Oral Treatment for Multidrug-Resistant Escherichia Coli in Acute Bacterial Prostatitis
Fosfomycin Trometamol Salt, control group - Prostatitis, Escherichia Coli Infection
Phase 4CompletedHospital Mutua de Terrassa882022-01-252026-10-28
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy
Phase 4CompletedBeth Israel Deaconess Medical Center1432021-12-122024-01-30
Deprescribing Tamsulosin in Older Men
Tamsulosin, Placebo - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Phase 4CompletedUniversity of California, San Francisco312021-09-182025-08-22
Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)
Tranexamic acid - Kidney Calculi, Urologic Diseases
Phase 4CompletedNorthwestern University1102021-09-172026-10-15
Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome
1% Atropine drops, Epinephrine - Intraoperative Floppy Iris Syndrome, Cataract
Phase 4CompletedUniversity Hospital Olomouc1642020-07-012024-02-20
Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms.
oral combination of colostrum and Serenoa repens extracts (PROSTYM®) - Chronic Prostatitis (CP), Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Phase 4CompletedClinica Urologica Molinette - Città della Saliute e della Scienza422020-03-012025-01-31
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Apalutamide, Placebo, Androgen-deprivation Therapy (ADT) - Prostatic Neoplasms
Phase 4CompletedJanssen Research & Development, LLC752019-12-172026-07-30
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
Enzalutamide - Prostatic Neoplasms, Castration-Resistant
Phase 4CompletedRadboud University Medical Center572019-05-302024-06-12
Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
Sildenafil, Ningmitai capsule, Ningbitai capsule + sildenafil - Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction
Phase 4CompletedXintian Pharmaceutical2542019-03-192023-10-12
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
Rosuvastatin 20mg, surgical castration - Prostate Cancer Metastatic
Phase 4CompletedNational Cancer Institute, Egypt702019-01-152021-03-02
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
Ciprofloxacin, Trimethoprim/Sulfamethoxazole, Fosfomycin - Complication, Infection
Phase 4CompletedRadboud University Medical Center15382018-04-032022-05-10
Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Leuprorelin Acetate (Eligard® 45 mg). - Prostate Cancer
Phase 4CompletedZodiac Produtos Farmaceuticos S.A.482017-11-142022-03-31
Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
Silodosin, Tamsulosin - Benign Prostatic Hyperplasia
Phase 4CompletedBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1412017-08-312019-09-27
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
Propofol, isoflurane, sevoflurane or desflurane - Cancer, Breast, Cancer Colorectal
Phase 4CompletedPeter MacCallum Cancer Centre, Australia1692017-08-272022-06-09

Showing 20 of 131. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (64)  ·  Prostatic Hyperplasia (61)  ·  Lower Urinary Tract Symptoms (14)  ·  Breast Neoplasms (6)  ·  Pain (6)  ·  Prostatitis (6)  ·  Urinary Bladder, Overactive (6)  ·  Neoplasms (5)  ·  Erectile Dysfunction (3)  ·  Hypogonadism (3)  ·  Anxiety Disorders (2)  ·  Coronary Artery Disease (2)  ·  Kidney Diseases (2)  ·  Melanoma (2)  ·  Metabolic Syndrome (2)

Broader conditions

Genital Diseases (131)  ·  Genital Diseases, Male (131)  ·  Male Urogenital Diseases (131)  ·  Urogenital Diseases (130)  ·  Genital Neoplasms, Male (65)  ·  Neoplasms by Site (65)  ·  Urogenital Neoplasms (65)  ·  Neoplasms (60)  ·  Pathological Conditions, Signs and Symptoms (34)  ·  Signs and Symptoms (29)  ·  Urological Manifestations (21)  ·  Female Urogenital Diseases (13)  ·  Female Urogenital Diseases and Pregnancy Complications (13)  ·  Urologic Diseases (12)

Interventions

Tamsulosin (16)  ·  Zoledronic Acid (14)  ·  Dutasteride (10)  ·  alfuzosin (8)  ·  silodosin (6)  ·  Leuprolide (4)  ·  Tadalafil (4)  ·  luprolide acetate gel depot (4)  ·  Ciprofloxacin (3)  ·  Solifenacin Succinate (3)  ·  Triptorelin Pamoate (3)  ·  bicalutamide (3)  ·  enzalutamide (3)  ·  Androgen Antagonists (2)  ·  Desflurane (2)

Sponsors

Novartis Pharmaceuticals (9)  ·  Sanofi (8)  ·  GlaxoSmithKline (7)  ·  Astellas Pharma Inc (6)  ·  Boehringer Ingelheim (4)  ·  Novartis (4)  ·  Samsung Medical Center (4)  ·  JW Pharmaceutical (3)  ·  American Medical Systems (2)  ·  Clinica Urologica Molinette - Città della Saliute e della Scienza (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Mansoura University (2)  ·  Pierre Fabre Medicament (2)  ·  RECORDATI GROUP (2)  ·  Radboud University Medical Center (2)

Countries

United States (31)  ·  Italy (14)  ·  South Korea (14)  ·  Canada (11)  ·  France (11)  ·  Spain (11)  ·  Germany (8)  ·  Netherlands (7)  ·  Egypt (6)  ·  Japan (6)  ·  Greece (5)  ·  Taiwan (5)  ·  Australia (4)  ·  China (4)  ·  Czechia (4)

Top investigators

Kyu-Sung Lee, Ph.D (4)  ·  Ahmed M Elshal, MD (2)  ·  Hassan Razvi, MD, FRCSC (2)  ·  Paul F Siami, MD (2)  ·  Albert Dahan, MD {hD (1)  ·  Alexis Te, MD (1)  ·  Alvin M Matsumoto, MD (1)  ·  Andrey Z Vinarov, PhD (1)  ·  Anne Sophie P. Kancir, MD PhD (1)

Results publications

PMID 10411041, PMID 19524353, PMID 23334883, PMID 31937091, PMID 16465187, PMID 17724727, PMID 19143027, PMID 19394149, PMID 19732305, PMID 21251673, PMID 21575967, PMID 21738005, PMID 22010203, PMID 23452344, PMID 24354113, PMID 25038794, PMID 25261801, PMID 25613154, PMID 25627076, PMID 25988518, PMID 26544316, PMID 27286961, PMID 27324263, PMID 29044968, PMID 29394114, PMID 30028657, PMID 30224019, PMID 30300367, PMID 30787085, PMID 31148056, PMID 31329922, PMID 31961963, PMID 32558340, PMID 33245533, PMID 34068083, PMID 34350976, PMID 35280654, PMID 36222618, PMID 36419331, PMID 36480560, PMID 37101774, PMID 37160401, PMID 38485614, PMID 40365426, PMID 40389061, PMID 40977319, PMID 41729277, PMID 42406401, PMID 4723349

NIH funding

2014 (1), 2015 (1), 2019 (1), K12DK111028 (1), R01CA138627 (1)